DAX24.046 +0,1%Est505.726 ±0,0%MSCI World4.343 -0,1%Top 10 Crypto11,92 -1,1%Nas23.465 -0,5%Bitcoin77.404 -0,1%Euro1,1639 ±-0,0%Öl62,39 -2,3%Gold4.188 -0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Bayer BAY001 NVIDIA 918422 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Siemens Energy ENER6Y TKMS thyssenkrupp Marine Systems TKMS00 Lufthansa 823212 Volkswagen (VW) vz. 766403 Deutsche Telekom 555750 Infineon 623100 Novo Nordisk A3EU6F SAP 716460 Vonovia A1ML7J BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt marginal fester -- Paramount will Netflix-Deal ausstechen -- Siemens und Healthineers kooperieren mit Rheinmetall -- D-Wave, Tesla, BioNTech, Novo Nordisk, TKMS im Fokus
Top News
Wie viel Gewinn ein Investment in Bitcoin Cash von vor 5 Jahren abgeworfen hätte Wie viel Gewinn ein Investment in Bitcoin Cash von vor 5 Jahren abgeworfen hätte
Ethereum Classic: So hätte sich ein Investment von vor 5 Jahren ausgezahlt Ethereum Classic: So hätte sich ein Investment von vor 5 Jahren ausgezahlt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
700 % in 7 Jahren: Wie BIT Capital mit Tech, Daten & Timing die Nasdaq schlägt.

EQS-Adhoc: Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026

08.12.25 14:53 Uhr
Werte in diesem Artikel
Aktien
Carl Zeiss Meditec AG
41,52 EUR -1,90 EUR -4,38%
Charts|News|Analysen
Aktie kaufen

EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Personnel
Carl Zeiss Meditec AG: Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026

08-Dec-2025 / 14:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung

Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 –
interim assumption of the Chairmanship of the Supervisory Board by Peter Kameritsch
 
Jena, 8 December 2025
The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) and Maximilian Foerst have mutually agreed to terminate Maximilian Foerst’s Executive Board mandate as of 31 December 2025.

The reason for this decision is a violation, acknowledged by Maximilian Foerst, of the ZEISS Group’s internal Code of Conduct in connection with a conflict of interest involving interactions with an individual within the ZEISS internal working environment, which dates back several years. The case is not related to the business activities of ZEISS Group or to the business of Carl Zeiss Meditec AG.

The Supervisory Board is working at full speed to identify a successor. On an interim basis, Andreas Pecher, currently Chairman of the Supervisory Board of Carl Zeiss Meditec AG and CEO of Carl Zeiss AG, will assume the role of CEO of Carl Zeiss Meditec AG as of 1 January 2026. He will resign from his Supervisory Board mandate beforehand. The Supervisory Board will be chaired on an interim basis by Peter Kameritsch.

Accordingly, as of 1 January 2026, the Executive Board of Carl Zeiss Meditec AG will consist of Andreas Pecher (Chief Executive Officer, ad interim) and Justus Felix Wehmer (Chief Financial Officer).

The successfully initiated strategic realignment under Maximilian Foerst will continue at an unchanged pace.
 
 

Contact for investors and press

Sebastian Frericks

Head of Group Finance & Investor Relations

Carl Zeiss Meditec AG

Tel.: +49 3641 220-116

E-Mail: investors.med@zeiss.com

Wer­bung

 

 

 

 

 

 

 

 

 



End of Inside Information

08-Dec-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2241862

 
End of Announcement EQS News Service
Wer­bung

2241862  08-Dec-2025 CET/CEST

Ausgewählte Hebelprodukte auf Carl Zeiss Meditec

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Carl Zeiss Meditec

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Carl Zeiss Meditec AG

DatumMeistgelesen
Wer­bung

Analysen zu Carl Zeiss Meditec AG

DatumRatingAnalyst
18:16Carl Zeiss Meditec OverweightBarclays Capital
17:06Carl Zeiss Meditec Sector PerformRBC Capital Markets
26.11.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
24.11.2025Carl Zeiss Meditec OverweightBarclays Capital
28.10.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
DatumRatingAnalyst
18:16Carl Zeiss Meditec OverweightBarclays Capital
24.11.2025Carl Zeiss Meditec OverweightBarclays Capital
20.10.2025Carl Zeiss Meditec OutperformBernstein Research
10.09.2025Carl Zeiss Meditec OverweightBarclays Capital
11.08.2025Carl Zeiss Meditec BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
17:06Carl Zeiss Meditec Sector PerformRBC Capital Markets
26.11.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
24.10.2025Carl Zeiss Meditec HoldDeutsche Bank AG
26.09.2025Carl Zeiss Meditec HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
15.09.2025Carl Zeiss Meditec Sector PerformRBC Capital Markets
DatumRatingAnalyst
28.10.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
17.10.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
12.09.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
08.08.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.
07.08.2025Carl Zeiss Meditec UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Carl Zeiss Meditec AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen